Bastiaan Sallevelt

94 CHAPTER 2.2 Table SI1.2. Continued. STOPP Action Clarity rating n=80 D5 Benzodiazepines 67% D11 Acetylcholinesterase inhibitors 67% G4 Benzodiazepines 67% H2 NSAID 67% H6 Long-term NSAID or colchicine (>3 months) 67% I2 Selective alpha-1 selective alpha blockers 67% J3 Beta-blockers 67% J4 Oestrogens 67% J6 Androgens (male sex hormones) 67% K1 Benzodiazepines 67% L2 Use of regular (as distinct from PRN) opioids 67% D6 Antipsychotics (i.e. other than quetiapine or clozapine) 75% D12 Phenothiazines 75% G2 Systemic corticosteroids 75% H1 Non-steroidal anti-inflammatory drug (NSAID) other than COX-2 selective agents 75% H3 Long-term use of NSAID (>3 months) 75% H9 Oral bisphosphonates 75% C1 Long-term aspirin at doses greater than 160mg per day 83% D13 Levodopa or dopamine agonists 83% H4 Long-term corticosteroids (>3 months) 83% H5 Corticosteroids (other than periodic intra-articular injections for mono-articular pain) 83% H7 COX-2 selective NSAIDs 83% J5 Oral oestrogens 83% C2 Aspirin 92% A1 Any drug 100% A2 Any drug 100% B1 Digoxin 100% B2 Verapamil or diltiazem 100% B5 Amiodarone 100% C4 Aspirin plus clopidogrel 100%